In press releases on Tuesday, April 16, Apple and Qualcomm announced they had agreed to settle all disputes worldwide. “Qualcomm and Apple today announced an agreement to dismiss all litigation between the two companies worldwide”.
The companies—one the maker of iPhones, the other one of the largest providers of mobile chips—added that, effective 1 April, they had reached a six-year licensing agreement and a multiyear chipset supply agreement, including a two-year option to extend.
The settlement includes an undisclosed payment from Apple to Qualcomm as well as a chipset supply agreement, suggesting that Apple will buy Qualcomm chips for future iPhones. The companies did not say how much the payment will be.
The legal battle dates back to 2017, spreading over three continents with Apple suing Qualcomm for over $1 billion in unpaid royalty rebates and accusing the San Diego chip company of anticompetitive patent licensing practices.
Full Content: New York Times, Qualcomm, Apple
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
South Africa Approves Canal+ MultiChoice Deal
May 21, 2025 by
CPI
WhatsApp Co-Founder Undermines Antitrust Allegations Against Meta in Court Testimony
May 21, 2025 by
CPI
OpenAI Acquires Jony Ive’s io for $6.4B to Pioneer Post-Smartphone Devices
May 21, 2025 by
CPI
Dior Commits €2 Million to Labor Initiatives in Italian Antitrust Settlement
May 21, 2025 by
CPI
Indonesia’s Antitrust Watchdog Probes Potential Risks of Grab-GoTo Merger
May 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros